They don't even have the U.S. rights to market the product here. This is a very odd company. Execs handing themselves thousands of free shares though.
It'll take until heading into Phase 3 before anything happens. People are waiting and investing elsewhere until then
Not sure about that but I'm staying long
I bought more today and it's rare that I buy a Biotech after a good run up, I usually prefer to bottom feed.
I have a good feeling about Idra
I should have told you I sold a few shares today. Almost a guarantee of a stock going up!
Kept the bulk of my shares, just sold a few so I could buy more Idra
I sure wouldn't short it but investors are probably waiting for an uptick before investing heavily in EZCH. The stock trends sideways for a long time. I sold a few shares today, which is probably why it went up, but I'm keeping the bulk of it.
I have a lot of patience, but I would love to see a bidding war by Cisco, ZTE, and other companies for EZCH.
From March 6. This company really needs to do some PR
Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors’ attention, and produce big gains as well. However, these can also lead on the downside when the growth story is over, so it is important to find companies which are still seeing strong growth prospects in their businesses.
One such company that might be well-positioned for future earnings growth is EZchip Semiconductor Ltd. (EZCH). This firm, which is in the Semiconductor industry, saw EPS growth of 34.6% last year, and is looking great for this year too.
In fact, the current growth estimate for this year calls for earnings-per-share growth of 33.8%. Furthermore, the long-term growth rate is currently an impressive 19.1% suggesting pretty good prospects for the long haul.
And if this wasn’t enough, the stock has actually seen estimates rise over the past month for the current fiscal year by about 2.6%. Thanks to this rise in earnings estimates, EZCH has a Zacks Rank #2 (Buy) which further underscores the potential for outperformance in this company.
So if you are looking for a fast growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider EZCH. Not only does it have double digit earnings growth prospect, but its impressive Zacks Rank suggests that analysts believe better days are ahead for EZCH as well.
That's my favorite holding right now. Staying long with LJPC as well
There really was no reason for even mentioning EOA since nobody was investing in xoma because of it. I thought that was odd as well. Reduce stock price, then buy more. Sure seems that way
I've been in xoma for a long long time. The BB didn't buy into xoma for OAH-that was not a focus of the drug, just a wild shot. There's a reason Camacord and that other house reiterated their buy rating. Eyeguard is the closest to getting approved, I gaurantee that's why BB got in.